<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Iran J Pharm Res</journal-id><journal-id journal-id-type="iso-abbrev">Iran J Pharm Res</journal-id><journal-id journal-id-type="doi">10.5812/ijpr</journal-id><journal-id journal-id-type="publisher-id">Brieflands</journal-id><journal-title-group><journal-title>Iranian Journal of Pharmaceutical Research : IJPR</journal-title></journal-title-group><issn pub-type="ppub">1735-0328</issn><issn pub-type="epub">1726-6890</issn><publisher><publisher-name>Brieflands</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">PMC9420214</article-id><article-id pub-id-type="doi">10.5812/ijpr-127036</article-id><article-categories><subj-group subj-group-type="heading"><subject>Rapid Communication</subject></subj-group></article-categories><title-group><article-title>A Neglected Challenge in the Analysis of Active Pharmaceutical Substances with Aldehyde Functional Group in Aqueous Matrices</article-title></title-group><contrib-group><contrib id="idm628d31dae41ca" contrib-type="author"><name><surname>Nasiri</surname><given-names>Azadeh</given-names></name><email>a.nasiri@sbmu.ac.ir</email><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib id="idm628d31dae41df" contrib-type="author"><name><surname>Mokhtari</surname><given-names>Shaya</given-names></name><email>sh.mokhtari@sbmu.ac.ir</email><xref rid="aff3" ref-type="aff">3</xref><xref rid="aff4" ref-type="aff">4</xref></contrib><contrib id="idm628d31dae41e9" contrib-type="author"><name><surname>Daraei</surname><given-names>Bahram</given-names></name><email>bdaraei@sbmu.ac.ir</email><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib id="idm628d31dae41ef" contrib-type="author"><name><surname>Yazdanpanah</surname><given-names>Hassan</given-names></name><email>yazdanpanah@sbmu.ac.ir</email><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib id="idm628d31dae41f7" contrib-type="author"><name><surname>Faizi</surname><given-names>Mehrdad</given-names></name><email>m.faizi@sbmu.ac.ir</email><xref rid="aff1" ref-type="aff">1</xref><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6896-838X</contrib-id></contrib><contrib id="idm628d31dae41fd" contrib-type="author"><name><surname>Kobarfard</surname><given-names>Farzad</given-names></name><email>farzadkf@yahoo.com</email><xref rid="aff5" ref-type="aff">5</xref><xref rid="aff4" ref-type="aff">4</xref><xref rid="aff3" ref-type="aff">3</xref><xref rid="cor628d31dae420b" ref-type="corresp">*</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Department of Pharmacology and Toxicology, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran</aff><aff id="aff2"><label>2</label>Food Safety Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran</aff><aff id="aff3"><label>3</label>Central Research Laboratories, Shahid Beheshti University of Medical Sciences, Tehran, Iran</aff><aff id="aff4"><label>4</label>Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran</aff><aff id="aff5"><label>5</label>Department of Medicinal Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran</aff><author-notes><corresp id="cor628d31dae420b"><label>*</label>Corresponding Author: Department of Medicinal Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Email: <email>farzadkf@yahoo.com</email></corresp></author-notes><pub-date pub-type="epub"><day>24</day><month>5</month><year>2022</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2022</year></pub-date><volume>21</volume><issue>1</issue><elocation-id>e127036</elocation-id><history><date date-type="received"><day>22</day><month>2</month><year>2022</year></date><date date-type="accepted"><day>05</day><month>3</month><year>2022</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2022, Author(s)</copyright-statement><copyright-year>2022</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (<ext-link xlink:href="https://creativecommons.org/licenses/by-nc/4.0/" ext-link-type="uri">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Aldehydes are compounds that are widely used and popular in organic synthesis due to their high reactivity. This advantage is a disadvantage in medicinal chemistry. Due to the ability of aldehydes to participate in nucleophilic reactions (especially in aqueous biological media) and access to nucleophiles such as amino acids and nucleic acids, drugs with aldehyde functional groups are always used with caution and carefully quantified in biological fluids. Our experience in working on biologically active aldehydes indicates the transformation of these groups of compounds in aqueous or alcoholic solution and thus the failure of analytical methods for their accurate monitoring in such media. Both mass spectrometry and Proton nuclear magnetic resonance spectroscopic findings indicate the reaction of spiramycin with water molecules in an aqueous solution, resulting in the conversion of spiramycin to a new molecule with 18 mass unit difference and thus, the residue amount which is measured and reported based on a mass spectrometries method does not show the correct amount of spiramycin in these samples.</p></abstract><kwd-group kwd-group-type="author"><kwd>Aldehyde</kwd><kwd>LC-MS/MS</kwd><kwd>MRM</kwd><kwd>Solvent</kwd><kwd>Spiramycin</kwd><kwd>NMR</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>1. Introduction</title><p>Aldehydes are well known as very reactive chemicals in organic chemistry. They are considered intrinsically high reactive building blocks and thus favored by synthetic organic chemists. In medicinal chemistry, however, the aldehyde functional group (formyl group) is generally considered not so safe functional group due to its rapid reaction with a variety of nucleophiles in biological systems, such as the amino group in proteins and nucleic acids. Regardless of their favored nature in organic synthesis and unfavored nature in medicinal chemistry, aldehydes should be considered challenging when it comes to their detection and determination in analytical chemistry (<xref rid="A127036REF1" ref-type="bibr">1</xref>).</p></sec><sec><title>2. Concepts</title><p>It has been well demonstrated that water adds rapidly to the carbonyl functional group of aldehydes to form geminal diol (<xref rid="A127036FIG1" ref-type="fig">Figure 1</xref>). In a similar reaction, alcohols add reversibly to aldehydes to form hemiacetals (<xref rid="A127036REF2" ref-type="bibr">2</xref>). This reaction can continue by adding another alcohol to form an acetal (<xref rid="A127036FIG2" ref-type="fig">Figure 2</xref>).</p><fig position="float" id="A127036FIG1" fig-type="inline"><label>Figure 1.</label><caption><title>Addition of water molecule to the carbonyl functional group of aldehydes to form geminal diol</title></caption><graphic xlink:href="ijpr-21-1-127036-i001" position="float"/></fig><fig position="float" id="A127036FIG2" fig-type="inline"><label>Figure 2.</label><caption><title>Addition of alcohols to aldehydes to form hemiacetals and acetals</title></caption><graphic xlink:href="ijpr-21-1-127036-i002" position="float"/></fig><p>The efficiency of addition reactions to an aldehyde is determined by how electrophilic the carbonyl carbon atom is. The partial positive charge of the carbon is magnified by the presence of the electron-withdrawing group attached to carbonyl and suppressed by the presence of electron-donating groups. Therefore, aliphatic aldehydes are more reactive than aromatic aldehydes in reaction with water or alcohol.</p><p>The high reactivity of aldehydes in aqueous or alcoholic solution to form geminal diols or acetals could be troublesome when aldehydes are to be detected and/or quantitatively determined in the solutions, particularly in biological fluids.</p><p>From an analytical chemistry point of view, the molecular transformation of aldehydes to their corresponding geminal diol or acetals in aqueous or alcoholic media would be a lethal incident because the target analysis changes its nature during the process of monitoring. The problem becomes more dramatic when mass spectrometry is used to monitor the target molecule. The unique sensitivity and specificity of analytical methods (which are developed based on mass spectrometric detection) totally depend on the integrity of the chemical structure of a molecule. Should the chemical structure of a target compound be changed during the application of the method, the great and competent ms-based method will fail despite its all greatness and capacities. Our experience in working on biologically active aldehydes indicates the transformation of these groups of compounds in aqueous or alcoholic solution and thus the failure of analytical methods for their accurate monitoring in such media (<xref rid="A127036REF3" ref-type="bibr">3</xref>).</p><p>Although the occurrence of an aldehyde functional group is not so often in active pharmaceutical ingredients (API), there are still quite a few important medications with the aldehyde group in their structures. Streptomycin is an essential medicine recognized by the World Health Organization (WHO) for the treatment of various infections, particularly tuberculosis (<xref rid="A127036REF4" ref-type="bibr">4</xref>). It was discovered at Rutgers University as the first-in-class aminoglycoside in 1944, and its use led to a dramatic reduction in the death rate of tuberculosis around the world (<xref rid="A127036REF1" ref-type="bibr">1</xref>). Streptomycin bears an aliphatic aldehyde in its structure, and one may speculate that the aldehyde will react with water molecules in an aqueous solution (<xref rid="A127036FIG3" ref-type="fig">Figure 3</xref>) (<xref rid="A127036REF5" ref-type="bibr">5</xref>).</p><fig position="float" id="A127036FIG3" fig-type="inline"><label>Figure 3.</label><caption><title>Streptomycin</title></caption><graphic xlink:href="ijpr-21-1-127036-i003" position="float"/></fig><p>7 aldehyde-containing, 16-membered macrolide antibiotics are now clinically used across the world (<xref rid="A127036REF6" ref-type="bibr">6</xref>). As metabolites of various <italic>Streptomyces</italic> strains, these macrolides were first identified in the 1950s and 1960s. The first isolated members of the family (i.e., spiramycin and tylosin) best depict their structures (<xref rid="A127036FIG4" ref-type="fig">Figure 4</xref>) (<xref rid="A127036REF1" ref-type="bibr">1</xref>).</p><fig position="float" id="A127036FIG4" fig-type="inline"><label>Figure 4.</label><caption><title>The chemical structures of tylosin, spiramycins I, II, III, and neospiramycins I, II, and III.</title></caption><graphic xlink:href="ijpr-21-1-127036-i004" position="float"/></fig><p>The mixture of spiramycin is a combination of spiramycins I, II, and III (<xref rid="A127036FIG4" ref-type="fig">Figure 4</xref>), of which spiramycin I is the majority of the mixture (<xref rid="A127036REF7" ref-type="bibr">7</xref>). Spiramycin is converted to neospiramycin (<xref rid="A127036FIG4" ref-type="fig">Figure 4</xref>), which is the main metabolite with an estimated antibacterial activity of 88% when compared to spiramycin (<xref rid="A127036REF8" ref-type="bibr">8</xref>).</p><p>Dissolving spiramycin (molecular weight: 843.6 g/mol) in water and monitoring its mass spectrum in an electrospray ionization (ESI) system (<xref rid="A127036FIG5" ref-type="fig">Figure 5</xref>) show an extra peak at 861.5 m/z, which is in agreement with the addition of 1 water molecule to the spiramycin structure (<xref rid="A127036FIG6" ref-type="fig">Figure 6</xref>).</p><fig position="float" id="A127036FIG5" fig-type="inline"><label>Figure 5.</label><caption><title>The mass spectra of spiramycin aqueous standard solution (Spiramycin: 843.60 m/z; H<sub>2</sub>O-bound spiramycin: 861.5 m/z).</title></caption><graphic xlink:href="ijpr-21-1-127036-i005" position="float"/></fig><fig position="float" id="A127036FIG6" fig-type="inline"><label>Figure 6.</label><caption><title>Addition of water molecules to the spiramycin structure.</title></caption><graphic xlink:href="ijpr-21-1-127036-i006" position="float"/></fig><p>Furthermore, the methanolic solution of spiramycin shows an extra peak at 875.7 m/z, corresponding to the addition of a molecule of methanol to the spiramycin (<xref rid="A127036FIG7" ref-type="fig">Figures 7</xref> and <xref rid="A127036FIG8" ref-type="fig">8</xref>).</p><fig position="float" id="A127036FIG7" fig-type="inline"><label>Figure 7.</label><caption><title>The mass spectra of spiramycin aqueous standard solution (Spiramycin: 843.60 m/z; Methanol-bound spiramycin: 875.7 m/z).</title></caption><graphic xlink:href="ijpr-21-1-127036-i007" position="float"/></fig><fig position="float" id="A127036FIG8" fig-type="inline"><label>Figure 8.</label><caption><title>Addition of methanol molecules to the spiramycin structure</title></caption><graphic xlink:href="ijpr-21-1-127036-i008" position="float"/></fig><p>The ESI mass spectrum of ethanolic solution of spiramycin shows the same extra peak with a 14 mass unit difference, which is in line with the ethanolic hemiacetal formation of spiramycin. In order to reconfirm the transformation of the formyl group of spiramycin to a geminal diol in an aqueous solution, the 1H NMR (Proton nuclear magnetic resonance) spectrum of a solution of spiramycin in D<sub>2</sub>O was acquired (<xref rid="A127036FIG9" ref-type="fig">Figure 9</xref>). As it appears from 1H NMR, the integration of the formyl signal (H<sub>A</sub> in <xref rid="A127036FIG4" ref-type="fig">Figure 4</xref>.) at 9.6 ppm shows a 30% reduction, which is due to the formyl group reaction with D2O.</p><fig position="float" id="A127036FIG9" fig-type="inline"><label>Figure 9.</label><caption><title>The <sup>1</sup>H-NMR spectrum of spiramycin pure standard dissolved in A, d6- DMSO; and B, Mixture of d6- DMSO and D<sub>2</sub>O.</title></caption><graphic xlink:href="ijpr-21-1-127036-i009" position="float"/></fig><p>Both mass spectrometric and <sup>1</sup>H NMR spectroscopic findings indicate the reaction of spiramycin with water molecules in an aqueous solution, resulting in the conversion of spiramycin to a new molecule with 18 mass unit difference. If an analytical method is set up based on monitoring the molecular mass of spiramycin to its diol derivative in an aqueous solution, it will cause a significant error in the accuracy of measurement. This becomes more problematic when we know that the Codex Alimentarius has set up a maximum residue limit (MRL) for spiramycin in different foods such as milk (200 &#x000b5;g/kg) (<xref rid="A127036REF9" ref-type="bibr">9</xref>). It is conceivable that spiramycin is changed to its geminal diol derivative in such aqueous matrices, and thus the amount of spiramycin which is measured and reported for a sample based on validated mass spectrometric method does not represent the real (correct) amount of spiramycin in the sample due to the mass shift of spiramycin (MW = 843.6) to spiramycin hydrate (MW = 861.5).</p></sec><sec><title>3. Research Highlights</title><p>- The ability of aldehydes to participate in the nucleophilic reaction was mentioned.</p><p>- Our experience in aldehyde drugs indicates the transformation of these compounds in aqueous solutions. </p><p>- Spiramycin converts to a new molecule with the mass difference in biological fluids.</p></sec></body><back><fn-group><fn fn-type="other" id="afn1"><p><bold>Authors' Contribution: </bold>F. K. conceived the idea, A. N., S. M., B. D, H. Y., and M. F contributed to the design, implementation of the research, analysis of the results, and writing of the manuscript.</p></fn><fn fn-type="COI-statement" id="afn2"><p><bold>Conflict of Interests: </bold>There are no conflicts to declare.</p></fn><fn fn-type="other" id="afn3"><p><bold>Data Reproducibility: </bold>All the experiments have been repeated at least three times to make sure about the reproducibility of the data presented in the present report.</p></fn><fn fn-type="supported-by" id="afn4"><p><bold>Funding/Support: </bold>This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.</p></fn></fn-group><ref-list><ref id="A127036REF1"><label>1</label><element-citation publication-type="journal" publication-format="print" xlink:title="1.Gampe C, Verma VA. Curse or Cure? A Perspective on the Developability of Aldehydes as Active Pharmaceutical Ingredients. J Med Chem. 2020;63(23):14357-81. doi:10.1021/acs.jmedchem.0c01177. [PubMed:32916044]."><person-group person-group-type="author"><name><surname>Gampe</surname><given-names>C</given-names></name><name><surname>Verma</surname><given-names>VA</given-names></name></person-group><article-title>Curse or Cure? A Perspective on the Developability of Aldehydes as Active Pharmaceutical Ingredients.</article-title><source>J Med Chem.</source><year>2020</year><volume>63</volume><issue>23</issue><fpage>14357</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1021/acs.jmedchem.0c01177</pub-id><pub-id pub-id-type="pmid">32916044</pub-id></element-citation></ref><ref id="A127036REF2"><label>2</label><element-citation publication-type="journal" publication-format="print" xlink:title="Crespi AF, Sanchez VM, Vega D, Perez AL, Brondino CD, Linck YG, et al. Paramagnetic solid-state NMR assignment and novel chemical conversion of the aldehyde group to dihydrogen ortho ester and hemiacetal moieties in copper(ii)- and cobalt(ii)-pyridinecarboxaldehyde complexes. RSC Adv. 2021;11(33):20216-31. doi:10.1039/d1ra02512k. [PubMed:35479880]. [PubMed Central:PMC9033980]."><person-group person-group-type="author"><name><surname>Crespi</surname><given-names>AF</given-names></name><name><surname>Sanchez</surname><given-names>VM</given-names></name><name><surname>Vega</surname><given-names>D</given-names></name><name><surname>Perez</surname><given-names>AL</given-names></name><name><surname>Brondino</surname><given-names>CD</given-names></name><name><surname>Linck</surname><given-names>YG</given-names></name><etal>et al.</etal></person-group><article-title>Paramagnetic solid-state NMR assignment and novel chemical conversion of the aldehyde group to dihydrogen ortho ester and hemiacetal moieties in copper(ii)- and cobalt(ii)-pyridinecarboxaldehyde complexes.</article-title><source>RSC Adv.</source><year>2021</year><volume>11</volume><issue>33</issue><fpage>20216</fpage><lpage>31</lpage><!--<pub-id pub-id-type="pmcid">9033980</pub-id>--><pub-id pub-id-type="doi">10.1039/d1ra02512k</pub-id><pub-id pub-id-type="pmid">35479880</pub-id></element-citation></ref><ref id="A127036REF3"><label>3</label><element-citation publication-type="journal" publication-format="print" xlink:title="J&#x000f8;rgensen Karl&#x000a0;A. Hetero&#x02010;Diels&#x02212;Alder Reactions of Ketones &#x02014; A Challenge for Chemists. Eur J Org Chem. 2004;2004(10):2093-102. doi:10.1002/ejoc.200300766."><person-group person-group-type="author"><name><surname>J&#x000f8;rgensen</surname><given-names>K</given-names></name></person-group><article-title>Hetero&#x02010;Diels&#x02212;Alder Reactions of Ketones &#x02014; A Challenge for Chemists.</article-title><source>Eur J Org Chem.</source><year>2004</year><volume>2004</volume><issue>10</issue><fpage>2093</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1002/ejoc.200300766</pub-id></element-citation></ref><ref id="A127036REF4"><label>4</label><element-citation publication-type="journal" publication-format="print" xlink:title="Cohen KA, Stott KE, Munsamy V, Manson AL, Earl AM, Pym AS. Evidence for Expanding the Role of Streptomycin in the Management of Drug-Resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2020;64(9). doi:10.1128/AAC.00860-20. [PubMed:32540971]. [PubMed Central:PMC7449167]."><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>KA</given-names></name><name><surname>Stott</surname><given-names>KE</given-names></name><name><surname>Munsamy</surname><given-names>V</given-names></name><name><surname>Manson</surname><given-names>AL</given-names></name><name><surname>Earl</surname><given-names>AM</given-names></name><name><surname>Pym</surname><given-names>AS</given-names></name></person-group><article-title>Evidence for Expanding the Role of Streptomycin in the Management of Drug-Resistant Mycobacterium tuberculosis.</article-title><source>Antimicrob Agents Chemother.</source><year>2020</year><volume>64</volume><issue>9</issue><!--<pub-id pub-id-type="pmcid">7449167</pub-id>--><pub-id pub-id-type="doi">10.1128/AAC.00860-20</pub-id><pub-id pub-id-type="pmid">32540971</pub-id></element-citation></ref><ref id="A127036REF5"><label>5</label><element-citation publication-type="book" xlink:title="El-Maghrabey MH, El-Shaheny R, El Hamd MA, Al-Khateeb LA, Kishikawa N, Kuroda N. Aldehydes&#x02019; Sources, Toxicity, Environmental Analysis, and Control in Food. In: Vasanthy M, Sivasankar V, Sunitha TG, editors. Organic Pollutants: Toxicity and Solutions. Cham, Switzerland: Springer 2022. p. 117-51."><person-group person-group-type="author"><name><surname>El-Maghrabey</surname><given-names>MH</given-names></name><name><surname>El-Shaheny</surname><given-names>R</given-names></name><name><surname>El Hamd</surname><given-names>MA</given-names></name><name><surname>Al-Khateeb</surname><given-names>LA</given-names></name><name><surname>Kishikawa</surname><given-names>N</given-names></name><name><surname>Kuroda</surname><given-names>N</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Vasanthy</surname><given-names>M</given-names></name><name><surname>Sivasankar</surname><given-names>V</given-names></name><name><surname>Sunitha</surname><given-names>TG</given-names></name></person-group><article-title>Aldehydes&#x02019; Sources, Toxicity, Environmental Analysis, and Control in Food.</article-title><source>Organic Pollutants: Toxicity and Solutions.</source><year>2022</year><fpage>117</fpage><lpage>51</lpage><isbn>2524-6402&#x0000d;2524-6410</isbn><pub-id pub-id-type="doi">10.1007/978-3-030-72441-2_5</pub-id><publisher-loc>Cham, Switzerland</publisher-loc><publisher-name>Springer </publisher-name></element-citation></ref><ref id="A127036REF6"><label>6</label><element-citation publication-type="journal" publication-format="print" xlink:title="Wang J, Leung D. Determination of spiramycin and neospiramycin antibiotic residues in raw milk using LC/ESI-MS/MS and solid-phase extraction. J Sep Sci. 2009;32(4):681-8. doi:10.1002/jssc.200800599. [PubMed:19165836]."><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Leung</surname><given-names>D</given-names></name></person-group><article-title>Determination of spiramycin and neospiramycin antibiotic residues in raw milk using LC/ESI-MS/MS and solid-phase extraction.</article-title><source>J Sep Sci.</source><year>2009</year><volume>32</volume><issue>4</issue><fpage>681</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1002/jssc.200800599</pub-id><pub-id pub-id-type="pmid">19165836</pub-id></element-citation></ref><ref id="A127036REF7"><label>7</label><element-citation publication-type="journal" publication-format="print" xlink:title="Saleh H, Elhenawee M, Hussien EM, Ahmed N, Ibrahim AE. Validation of HPLC-UV Multi-Residue Method for the Simultaneous Determination of Tetracycline, Oxytetracycline, Spiramycin and Neospiramycin in Raw Milk. Food Anal Methods. 2020;14(1):36-43. doi:10.1007/s12161-020-01838-9."><person-group person-group-type="author"><name><surname>Arsic</surname><given-names>B</given-names></name><name><surname>Barber</surname><given-names>J</given-names></name><name><surname>Cikos</surname><given-names>A</given-names></name><name><surname>Mladenovic</surname><given-names>M</given-names></name><name><surname>Stankovic</surname><given-names>N</given-names></name><name><surname>Novak</surname><given-names>P</given-names></name></person-group><article-title>16-membered macrolide antibiotics: a review.</article-title><source>Int J Antimicrob Agents.</source><year>2018</year><volume>51</volume><issue>3</issue><fpage>283</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2017.05.020</pub-id><pub-id pub-id-type="pmid">28668674</pub-id></element-citation></ref><ref id="A127036REF8"><label>8</label><element-citation publication-type="journal" publication-format="print" xlink:title="Gaudin V, Hedou C, Soumet C, Verdon E. Multiplex immunoassay based on biochip technology for the screening of antibiotic residues in milk: validation according to the European guideline. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2018;35(12):2348-65. doi:10.1080/19440049.2018.1538572. [PubMed:30513250]."><person-group person-group-type="author"><name><surname>Saleh</surname><given-names>H</given-names></name><name><surname>Elhenawee</surname><given-names>M</given-names></name><name><surname>Hussien</surname><given-names>EM</given-names></name><name><surname>Ahmed</surname><given-names>N</given-names></name><name><surname>Ibrahim</surname><given-names>AE</given-names></name></person-group><article-title>Validation of HPLC-UV Multi-Residue Method for the Simultaneous Determination of Tetracycline, Oxytetracycline, Spiramycin and Neospiramycin in Raw Milk.</article-title><source>Food Anal Methods.</source><year>2020</year><volume>14</volume><issue>1</issue><fpage>36</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1007/s12161-020-01838-9</pub-id></element-citation></ref><ref id="A127036REF9"><label>9</label><element-citation publication-type="journal" publication-format="print" xlink:title=""><person-group person-group-type="author"><name><surname>Gaudin</surname><given-names>V</given-names></name><name><surname>Hedou</surname><given-names>C</given-names></name><name><surname>Soumet</surname><given-names>C</given-names></name><name><surname>Verdon</surname><given-names>E</given-names></name></person-group><article-title>Multiplex immunoassay based on biochip technology for the screening of antibiotic residues in milk: validation according to the European guideline.</article-title><source>Food Addit Contam Part A Chem Anal Control Expo Risk Assess.</source><year>2018</year><volume>35</volume><issue>12</issue><fpage>2348</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1080/19440049.2018.1538572</pub-id><pub-id pub-id-type="pmid">30513250</pub-id></element-citation></ref></ref-list></back></article>
